Elevated D-dimer and Adverse In-hospital Outcomes in COVID-19 Patients and Synergism with Hyperglycemia.

Haowei LiShimin ChenShengshu WangShan-Shan YangWenzhe CaoShaohua LiuYang SongXuehang LiZhiqiang LiRongrong LiXiong LiuChangjun WangYong ChenFei XieYao HeMiao Liu

Published in: Infection and drug resistance (2022)

Risk of adverse in-hospital outcomes is higher among patients with high D-dimer levels. Additionally, this study found for the first time that elevated D-dimer and hyperglycemia had a synergistic effect on COVID-19 prognosis, and this risk was independent of diabetes history.

Keyphrases

sars cov
adverse drug
coronavirus disease
healthcare
type diabetes
glycemic control
cardiovascular disease
acute care
diabetic rats
metabolic syndrome
adipose tissue
respiratory syndrome coronavirus
insulin resistance